1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Non-Tyrosine Kinase Inhibitors in Oncology Industry 2015 Market Research Report

Summary


The Global Non-Tyrosine Kinase Inhibitors in Oncology Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Non-Tyrosine Kinase Inhibitors in Oncology industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Non-Tyrosine Kinase Inhibitors in Oncology market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Non-Tyrosine Kinase Inhibitors in Oncology industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 220 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Non-Tyrosine Kinase Inhibitors in Oncology Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Non-Tyrosine Kinase Inhibitors in Oncology
1.2 Classification of Non-Tyrosine Kinase Inhibitors in Oncology
1.3 Applications of Non-Tyrosine Kinase Inhibitors in Oncology
1.4 Industry Chain Structure of Non-Tyrosine Kinase Inhibitors in Oncology
1.5 Industry Regional Overview of Non-Tyrosine Kinase Inhibitors in Oncology
1.6 Industry Policy Analysis of Non-Tyrosine Kinase Inhibitors in Oncology
1.7 Industry News Analysis of Non-Tyrosine Kinase Inhibitors in Oncology

2 Manufacturing Cost Structure Analysis of Non-Tyrosine Kinase Inhibitors in Oncology
2.1 Raw Material Suppliers and Price Analysis of Non-Tyrosine Kinase Inhibitors in Oncology
2.2 Equipment Suppliers and Price Analysis of Non-Tyrosine Kinase Inhibitors in Oncology
2.3 Labor Cost Analysis of Non-Tyrosine Kinase Inhibitors in Oncology
2.4 Other Costs Analysis of Non-Tyrosine Kinase Inhibitors in Oncology
2.5 Manufacturing Cost Structure Analysis of Non-Tyrosine Kinase Inhibitors in Oncology
2.6 Manufacturing Process Analysis of Non-Tyrosine Kinase Inhibitors in Oncology

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Global Key Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2014
3.3 RandD Status and Technology Source of Global Non-Tyrosine Kinase Inhibitors in Oncology Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Global Non-Tyrosine Kinase Inhibitors in Oncology Key Manufacturers in 2014

4 Production Analysis of Non-Tyrosine Kinase Inhibitors in Oncology by Regions, Technology, and Applications
4.1 Global Production of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (US, EU, China, Japan, etc.) 2010-2015
4.2 Global Production of Non-Tyrosine Kinase Inhibitors in Oncology by Technology 2010-2015
4.3 Global Production of Non-Tyrosine Kinase Inhibitors in Oncology by Applications 2010-2015
4.4 Price Analysis of Global Non-Tyrosine Kinase Inhibitors in Oncology Key Manufacturers in 2015
4.5 US Capacity, Production, Price, Cost and Revenue of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
4.6 EU Capacity, Production, Price, Cost and Revenue of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
4.7 Japan Capacity, Production, Price, Cost and Revenue of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
4.8 China Capacity, Production, Price, Cost and Revenue of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
4.9 US Supply, Import, Export and Consumption of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
4.10 EU Supply, Import, Export and Consumption of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
4.11 Japan Supply, Import, Export and Consumption of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
4.12 China Supply, Import, Export and Consumption of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015

5 Sales and Revenue Analysis of Non-Tyrosine Kinase Inhibitors in Oncology by Regions
5.1 Global Sales of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (US, EU, China, Japan, etc.) 2010-2015
5.2 Global Revenue of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (US, EU, China, Japan, etc.) 2010-2015
5.3 Global Price Analysis of Non-Tyrosine Kinase Inhibitors in Oncology Sales by Regions (US, EU, China, Japan, etc.) 2010-2015
5.4 Global Price, Cost and Gross of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015

6 Analysis of Non-Tyrosine Kinase Inhibitors in Oncology Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity and Production of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
6.2 Production Market Share Analysis of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
6.3 Sales Overview of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
6.4 Supply, Sales and Shortage of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
6.5 Import, Export and Consumption of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015

7 Analysis of Non-Tyrosine Kinase Inhibitors in Oncology Industry Key Manufacturers
7.1 Roche
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity Production Price Cost Production Value
7.1.4 Contact Information

7.2 Eli Lilly
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity Production Price Cost Production Value
7.2.4 Contact Information

7.3 Novartis
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity Production Price Cost Production Value
7.3.4 Contact Information

7.4 Array BioPharma
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity Production Price Cost Production Value
7.4.4 Contact Information

7.5 Nerviano Medical Sciences
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity Production Price Cost Production Value
7.5.4 Contact Information

7.6 Cyclacel Pharmaceuticals
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity Production Price Cost Production Value
7.6.4 Contact Information

7.7 Daiichi Sankyo
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity Production Price Cost Production Value
7.7.4 Contact Information

7.8 Onconova Therapeutics
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity Production Price Cost Production Value
7.8.4 Contact Information

7.9 AstraZeneca
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity Production Price Cost Production Value
7.9.4 Contact Information

7.10 GlaxoSmithKline (GSK)
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity Production Price Cost Production Value
7.10.4 Contact Information

7.11 Pfizer
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity Production Price Cost Production Value
7.11.4 Contact Information

7.12 Merck KGaA
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity Production Price Cost Production Value
7.12.4 Contact Information

7.13 Carna Biosciences
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity Production Price Cost Production Value
7.13.4 Contact Information

7.14 Astex Pharmaceuticals
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity Production Price Cost Production Value
7.14.4 Contact Information

7.15 Celgene Corporation
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity Production Price Cost Production Value
7.15.4 Contact Information

7.16 Jasco Pharmaceuticals
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity Production Price Cost Production Value
7.16.4 Contact Information

7.17 Eternity Bioscience
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity Production Price Cost Production Value
7.17.4 Contact Information

8 Price and Gross Margin Analysis
8.1 Analysis of Price, Supply and Consumption
8.1.1 Price Analysis
8.1.2 Supply Analysis
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Non-Tyrosine Kinase Inhibitors in Oncology Product Types
8.5 Market Share Analysis of Different Non-Tyrosine Kinase Inhibitors in Oncology Price Levels
8.6 Gross Margin Analysis of Different Non-Tyrosine Kinase Inhibitors in Oncology Applications

9 Marketing Trader or Distributor Analysis of Non-Tyrosine Kinase Inhibitors in Oncology
9.1 Marketing Channels Status of Non-Tyrosine Kinase Inhibitors in Oncology
9.2 Traders or Distributors of Non-Tyrosine Kinase Inhibitors in Oncology with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Non-Tyrosine Kinase Inhibitors in Oncology
9.4 Regional Import, Export and Trade Analysis of Non-Tyrosine Kinase Inhibitors in Oncology

10 Development Trend of Non-Tyrosine Kinase Inhibitors in Oncology Industry 2015-2020
10.1 Capacity and Production Overview of Non-Tyrosine Kinase Inhibitors in Oncology 2015-2020
10.2 Production Market Share Analysis of Non-Tyrosine Kinase Inhibitors in Oncology 2015-2020
10.3 Sales Overview of Non-Tyrosine Kinase Inhibitors in Oncology 2015-2020
10.4 Supply, Sales, and Shortage of Non-Tyrosine Kinase Inhibitors in Oncology 2015-2020
10.5 Import, Export and Consumption of Non-Tyrosine Kinase Inhibitors in Oncology 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Non-Tyrosine Kinase Inhibitors in Oncology 2015-2020

11 Industry Chain Suppliers of Non-Tyrosine Kinase Inhibitors in Oncology with Contact Information
11.1 Major Raw Materials Suppliers of Non-Tyrosine Kinase Inhibitors in Oncology with Contact Information
11.2 Manufacturing Equipment Suppliers of Non-Tyrosine Kinase Inhibitors in Oncology with Contact Information
11.3 Major Suppliers of Non-Tyrosine Kinase Inhibitors in Oncology with Contact Information
11.4 Key Consumers of Non-Tyrosine Kinase Inhibitors in Oncology with Contact Information
11.5 Supply Chain Relationship Analysis of Non-Tyrosine Kinase Inhibitors in Oncology

12 New Project Investment Feasibility Analysis of Non-Tyrosine Kinase Inhibitors in Oncology
12.1 New Project SWOT Analysis of Non-Tyrosine Kinase Inhibitors in Oncology
12.2 New Project Investment Feasibility Analysis of Non-Tyrosine Kinase Inhibitors in Oncology

13 Conclusion of the Global Non-Tyrosine Kinase Inhibitors in Oncology Industry 2015 Market Research Report




List of Tables and Figures
Figure Picture of Non-Tyrosine Kinase Inhibitors in Oncology
Table Product Specifications of Non-Tyrosine Kinase Inhibitors in Oncology
Figure Global Sales Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Product Types in 2014
Figure Global Sales Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Applications in 2014
Figure Industry Chain Structure of Non-Tyrosine Kinase Inhibitors in Oncology
Table Global Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers
Table Industry Policy of Non-Tyrosine Kinase Inhibitors in Oncology
Table Industry News List of Non-Tyrosine Kinase Inhibitors in Oncology
Table Manufacturing Cost Structure Analysis of Non-Tyrosine Kinase Inhibitors in Oncology in 2014
Figure Manufacturing Process Analysis of Non-Tyrosine Kinase Inhibitors in Oncology
Table Capacity (K Person-portion) and Commercial Production Date of Global Non-Tyrosine Kinase Inhibitors in Oncology Key Manufacturers in 2014
Table Manufacturing Plants Distribution of Global Key Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2014
Table RandD Status and Technology Source of Global Non-Tyrosine Kinase Inhibitors in Oncology Key Manufacturers in 2014
Table Raw Materials Sources Analysis of Global and China Non-Tyrosine Kinase Inhibitors in Oncology Key Manufacturers in 2014
Table Global Production of Non-Tyrosine Kinase Inhibitors in Oncology by Regions 2010-2015 (K Person-portion)
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Regions in 2010
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Regions in 2011
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Regions in 2012
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Regions in 2013
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Regions in 2014
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Regions in 2015
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Technology in 2010
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Technology in 2011
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Technology in 2012
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Technology in 2013
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Technology in 2014
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Technology in 2015
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Applications in 2010
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Applications in 2011
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Applications in 2012
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Applications in 2013
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Applications in 2014
Figure Global Production Market Share of Non-Tyrosine Kinase Inhibitors in Oncology by Applications in 2015
Figure Price Comparison of Global Non-Tyrosine Kinase Inhibitors in Oncology Key Manufacturers in 2015 (USD/Person-portion)
Table US Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
Table EU Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
Table Japan Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
Table China Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion) and Revenue (M USD) of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
Table US Supply, Import, Export and Consumption of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (K Person-portion)
Table EU Supply, Import, Export and Consumption of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (K Person-portion)
Table Japan Supply, Import, Export and Consumption of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (K Person-portion)
Table China Supply, Import, Export and Consumption of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (K Person-portion)
Table Global Sales of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (US, EU, China, Japan, etc.) 2010-2015 (K Person-portion)
Figure Global Sales of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (EU, China, Japan, etc.) in 2010 (K Person-portion)
Figure Global Sales of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (EU, China, Japan, etc.) in 2011 (K Person-portion)
Figure Global Sales of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (EU, China, Japan, etc.) in 2012 (K Person-portion)
Figure Global Sales of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (EU, China, Japan, etc.) in 2013 (K Person-portion)
Figure Global Sales of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (EU, China, Japan, etc.) in 2014 (K Person-portion)
Figure Global Sales of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (EU, China, Japan, etc.) in 2015 (K Person-portion)
Table Global Revenue of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (US, EU, China, Japan, etc.) 2010-2015 (M USD)
Figure Global Revenue of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (US, EU, China, Japan, etc.) in 2010 (M USD)
Figure Global Revenue of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (US, EU, China, Japan, etc.) in 2011 (M USD)
Figure Global Revenue of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (US, EU, China, Japan, etc.) in 2012 (M USD)
Figure Global Revenue of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (US, EU, China, Japan, etc.) in 2013 (M USD)
Figure Global Revenue of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (US, EU, China, Japan, etc.) in 2014 (M USD)
Figure Global Revenue of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (US, EU, China, Japan, etc.) in 2015 (M USD)
Table Sale Price of Non-Tyrosine Kinase Inhibitors in Oncology by Regions (US, EU, China, Japan, etc.) 2010-2015 (USD/Person-portion)
Figure Global Price Analysis of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (USD/Person-portion)
Figure Global Cost Analysis of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (USD/Person-portion)
Figure Global Gross Analysis of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
Table Global and Major Manufacturers Capacity of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (K Person-portion)
Table Global Capacity Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers 2010-2015
Table Global and Major Manufacturers Production of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (K Person-portion)
Table Global Production Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers 2010-2015
Figure Global Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
Figure Global Capacity Utilization Rate of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
Table Global and Major Manufacturers Revenue of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (M USD)
Table Global Revenue Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers 2010-2015
Figure Global Revenue (M USD) and Growth Rate of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
Table China and Major Manufacturers Capacity of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (K Person-portion)
Table Capacity Market Share of China Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers 2010-2015
Table China and Major Manufacturers Production 2010-2015 (K Person-portion)
Table Production Market Share of China Major Manufacturers 2010-2015
Figure China Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
Figure China Capacity Utilization Rate of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
Table China and Major Manufacturers Revenue of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (M USD)
Table Revenue Market Share of China Major Manufacturers 2010-2015
Figure China Revenue (M USD) and Growth Rate of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
Figure Global Production Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2010
Figure Global Production Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2011
Figure Global Production Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2012
Figure Global Production Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2013
Figure Global Production Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2014
Figure Global Production Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2015
Figure China Production Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2010
Figure China Production Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2011
Figure China Production Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2012
Figure China Production Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2013
Figure China Production Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2014
Figure China Production Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2015
Figure Global Sales (K Person-portion) and Growth Rate of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
Figure China Sales (K Person-portion) and Growth Rate of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
Table Global Supply, Sales and Shortage of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (K Person-portion)
Table China Supply, Sales and Shortage of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (K Person-portion)
Table China Import, Export and Consumption of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (K Person-portion)
Table Price of Global Non-Tyrosine Kinase Inhibitors in Oncology Major Manufacturers 2010-2015 (USD/Person-portion)
Figure Price Comparison by Global Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2014 (USD/Person-portion)
Table Gross Margin of Global Non-Tyrosine Kinase Inhibitors in Oncology Major Manufacturers 2010-2015
Figure Gross Margin of Global Non-Tyrosine Kinase Inhibitors in Oncology Major Manufacturers in 2014
Table Global and Major Manufacturers Revenue of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (M USD)
Table Global Revenue Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers 2010-2015
Figure Global Revenue Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2011
Figure Global Revenue Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2012
Figure Global Revenue Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2013
Figure Global Revenue Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2014
Figure Global Revenue Market Share of Major Non-Tyrosine Kinase Inhibitors in Oncology Manufacturers in 2015
Table China and Major Manufacturers of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015 (M USD)
Table Revenue Market Share of China Non-Tyrosine Kinase Inhibitors in Oncology Major Manufacturers 2010-2015
Table Global Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
Table China Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Non-Tyrosine Kinase Inhibitors in Oncology 2010-2015
Figure Roche Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table Roche Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 Roche Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Roche Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Roche Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure Eli Lilly Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table Eli Lilly Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 Eli Lilly Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Eli Lilly Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Eli Lilly Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure Novartis Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table Novartis Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 Novartis Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Novartis Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Novartis Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure Array BioPharma Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table Array BioPharma Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 Array BioPharma Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Array BioPharma Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Array BioPharma Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure Daiichi Sankyo Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table Daiichi Sankyo Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 Daiichi Sankyo Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Daiichi Sankyo Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Daiichi Sankyo Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure Onconova Therapeutics Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table Onconova Therapeutics Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 Onconova Therapeutics Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Onconova Therapeutics Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Onconova Therapeutics Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure AstraZeneca Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table AstraZeneca Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 AstraZeneca Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 AstraZeneca Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 AstraZeneca Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure GlaxoSmithKline (GSK) Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table GlaxoSmithKline (GSK) Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 GlaxoSmithKline (GSK) Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 GlaxoSmithKline (GSK) Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 GlaxoSmithKline (GSK) Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure Pfizer Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table Pfizer Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 Pfizer Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Pfizer Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Pfizer Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure Merck KGaA Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table Merck KGaA Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 Merck KGaA Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Merck KGaA Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Merck KGaA Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure Carna Biosciences Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table Carna Biosciences Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 Carna Biosciences Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Carna Biosciences Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Carna Biosciences Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure Celgene Corporation Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table Celgene Corporation Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 Celgene Corporation Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Celgene Corporation Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Celgene Corporation Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure Jasco Pharmaceuticals Non-Tyrosine Kinase Inhibitors in Oncology Product Picture
Table Jasco Pharmaceuticals Non-Tyrosine Kinase Inhibitors in Oncology Product Specification
Table 2010-2015 Jasco Pharmaceuticals Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) Price Cost Gross (USD/Person-portion) Production Value (Million USD) Gross Margin List
Figure 2010-2015 Jasco Pharmaceuticals Non-Tyrosine Kinase Inhibitors in Oncology Product Capacity Production (K Person-portion) and Growth Rate
Figure 2010-2015 Jasco Pharmaceuticals Non-Tyrosine Kinase Inhibitors in Oncology Product Production Global Market Share
Figure Eternity Bioscience Non-Tyro

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Sunitinib Malate Market: By Disease (Pancreatic Neuroendocrine Tumors & Kidney Cancer) & By Region (Europe, North America, Asia-Pacific & Rest of the World (RoW))-Forecast (2016-2021)

Sunitinib Malate Market: By Disease (Pancreatic Neuroendocrine Tumors & Kidney Cancer) & By Region (Europe, North America, Asia-Pacific & Rest of the World (RoW))-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Sunitinib, developed and marketed as Sutent by Pfizer Inc and previously known as SU11248, is a small-molecule medicine which has to be administered orally and has been proven to be effective in blocking ...

Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies

Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies

  • $ 4995
  • Industry report
  • September 2016
  • by GBI Research

Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies Summary Gastric cancer is characterized by the formation of malignant ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.